Financing - November 14, 2016
Novo Seeds and Almi Invest co-invest in rare disease start-up
Novo Seeds and Almi Invest are to jointly invest up to 6,3 million SEK in rare disease start-up Merozyne Therapeutics dependent on pre-agreed milestones. Merozyne Therapeutics aims to develop a small molecule inhibitor for the treatment of congenital muscular dystrophy (MDC1A). Currently there is no cure for MDC1A, which is caused by an absence of […]
Financing - November 8, 2016
Acarix receives double-digit SEK million investment
Acarix, a Swedish/Danish medical device company specializing in non-invasive, non-radiation acoustic detection of Coronary Artery Disease (CAD), has received a major strategic investment from the Chinese company Puhua Jingxin Guzhou Health Management Partnership (Puhua Jingxin). The aim of the double-digit million investment is to accelerate market introduction of the already CE-marked CADScorSystem. The system combines […]
Financing - November 3, 2016
Asarina Pharma raises EUR 7 million
Asarina Pharma, a drug development company focused on the development of a novel therapy for severe premenstrual symptoms, has completed a financing round raising EURO 7 million from new and existing investors for the continued clinical development of Sepranolone. Around 5% of women in fertile age worldwide suffer from Premenstrual Dysphoric Disorder (PMDD), a debilitating […]
Financing - October 28, 2016
Bonesupport raises $37 million
BONESUPPORT has raised $37 million (SEK 327 million) in a combination of equity and debt finance and the new funds will be used to deliver further value from its unique CERAMENT platform. The oversubscribed equity financing was led by Tellacq AB and was supported by the Company’s current major shareholders, including HealthCap, Lundbeckfond Ventures, Industrifonden, […]
Financing - September 27, 2016
Dilafor raises SEK 51 million
Karolinska Development announces that its portfolio company Dilafor, a drug development company focusing on the development of tafoxiparin for obstetric indications, has successfully completed a financing round raising SEK 51 million (US$5.9 million) from new and existing investors. The new investors include Lee’s Healthcare Industry Fund, Rosetta Capital IV and Pila AB. Dilafor’s largest existing […]
Financing - September 22, 2016
InDex Pharmaceuticals raises 250 million SEK
The Stockholm based company InDex Pharmaceuticals announces new issue of shares of SEK 250 million. The issue also includes an overallotment option of 25 million. The subscription period runs until September 27, 2016. InDex main owners SEB Venture Capital, Industrifonden and NeoMed Management has made significant subscription commitments in the issue of new shares, which through […]
